Volume 3, Issue 2 (6-2004)                   JRUMS 2004, 3(2): 113-119 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Comparison of the Results of Two Therapeutic Methods: Imipramine with Combination of Imipramine and Oxybutynin in Uncomplicated Nocturnal Enuresis in 6-12 Year Old Children. JRUMS 2004; 3 (2) :113-119
URL: http://journal.rums.ac.ir/article-1-5414-en.html
Abstract:   (1365 Views)
Background: Imipramine is one of the common drugs therapies in enuretic children which is effective 50-60% on average. The main purpose of this research was to investigate the therapeutic effect of the combination of imipramine and oxybutynin compared to imipramine alone in uncomplicated nocturnal enuretic children.
Materials and Methods:This clinical trial study was carried out on 80 primary school children (6-12 years old) with uncomplicated enuresis that were selected among 2500 school children with screening by questionnaire. The children were randomly divided into two groups (40 in each group). One group was treated with Imipramine in combination with Oxybutynin and the other group was treated with Imipramine and placebo for a period of 3 months. After the treatment period, the treated and untreated children were determined.
Results: The frequency of cured with Imipramine and Oxybutynin therapy was 95%, and with Imipramine and placebo was 60%; therefore there was a significant difference between the two therapeutic methods, clinically and statistically (P=0.00017).
Conclusion: The Result of this study showed that Imipramine and Oxybutynin treatment was more effective than Imipramine alone, although we recommend further studies to determine the rate of relapses and side effects of the above methods.
Key words: Enuresis, Imipramine, Oxybutynin
Full-Text [PDF 182 kb]   (263 Downloads)    
Type of Study: Research | Subject: Urology
Received: 2020/06/8 | Accepted: 2020/06/8 | Published: 2020/06/8

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Rafsanjan University of Medical Sciences

Designed & Developed by : Yektaweb